Hydroxychloroquine: Pharma companies boost production of the key medicines to meet demand

New Delhi: Assuring that the country has adequate supply of the anti-malaria tablets ‘Hydroxychloroquine’ for both domestic and export demand along with other key medicines, the Indian Pharmaceutical Alliance (IPA) on Sunday said that pharma companies are ramping up production of the key medicines to meet demand.

In a statement, the industry body applauded the government’s decision to remove restrictions on the export of the pharma products and said that it is in line with the India’s image as the “pharmacy of the world”.

“The decision to withdraw restrictions on 12 products and export Hydroxychloroquine is a reflection of India’s commitment to supply medicines at this critical time. IPA lauds Government of Indiaa�s positive move and is in line with image of India as the pharmacy of the world,” it said.

“We have adequate manufacturing capacity, today, in the country and have sufficient supply to meet both domestic and export demand. Zydus Cadila and IPCA are the major manufacturers of hydroxychloroquine in the country. The companies are ramping up production to ensure an uninterrupted supply for domestic and export market,” it added. (IANS)

Also Read: Centre lifts partial ban on hydroxychloroquine after Donald Trump request

Also watch: Coronavirus Preventive Measures: Dr. Navanil Barua in exclusive interview with The Sentinel Digital